Showing 8,801 - 8,820 results of 13,976 for search 'documents 12', query time: 0.15s Refine Results
  1. 8801
  2. 8802

    Recurrent maternal CMV infection associated with symptomatic congenital infection: results from a questionnaire study in Portugal by Paulo Paixão, Maria João Brito, Daniel Virella, Maria Teresa Neto

    Published 2019-09-01
    “…The odds for non-primary maternal infection if the offspring was symptomatic at birth were 6.2 (95% CI 1.2 to 32.27).Conclusion The reported number of confirmed cases of congenital CMV infection was much lower than expected. …”
    Get full text
    Article
  3. 8803
  4. 8804
  5. 8805

    Gross and Morphometric Anatomy of the Male Reproductive System of Bats (Eidolon helvum) by A. Danmaigoro, J. E. Onu, M. L. Sonfada, M. A. Umaru, S. A. Hena, A. Mahmuda

    Published 2014-01-01
    “…Morphologically, the mean body weight and forearm length in both adults and juveniles were 235.31±6.30 g, 12.14±0.19 cm and 69.54±7.68 g, 7.77±0.29 cm, respectively. …”
    Get full text
    Article
  6. 8806
  7. 8807
  8. 8808
  9. 8809
  10. 8810

    Case Report: Pediatric respiratory viral infection failure: a case series of eight fatalities in children under 5 years old in Iran by Mahnaz Ramzali, Saeed Samadizadeh, Mohsen Ebrahimi, Leila Barati, Britt Nakstad, Britt Nakstad, Alireza Tahamtan, Alireza Tahamtan

    Published 2025-05-01
    “…According to the World Health Organization (WHO), ARTI leads to the hospitalization of over 12 million children annually, with approximately one million fatalities, one-third of which occur in low-income countries. …”
    Get full text
    Article
  11. 8811
  12. 8812
  13. 8813
  14. 8814

    Seroprevalence and risk factors for sheep pox and goat pox among small ruminant herds from Nakapiripirit and Sembabule districts, Uganda by Nizeyimana Gerald, Ayebazibwe Chrisostom, Biryomumaisho Savino, Mayanja Franklin, Muhanguzi Dennis, Vudriko Patrick, Tweyongyere Robert, Erume Joseph

    Published 2025-07-01
    “…Seropositivity was greater in Nakapiripirit [n = 93, 12%] than in Sembabule districts [n = 44, 6%]. Although low in proportion, overall, from both districts, seropositivity among sheep [N = 296, n = 32,12%] was higher than goats [N = 1,219, n = 105,10%]. …”
    Get full text
    Article
  15. 8815

    Outcomes of chronic pectoralis major rupture repair with implant-free Achilles allograft by Abdul-ilah Hachem, MD, Diego Gonzalez-Morgado, MD, Peio Beristain, MD, Gonzalo Barraza, MD, Fernando Alvarado, MD, Karla Bascones, MD, Amr Elmaraghy, MD, Xavi Rius, MD

    Published 2025-08-01
    “…The mean delay in diagnosis and treatment was 5.5 months (2-12) and 12 ± 4.9 months, respectively. The overall cohort improved significantly regarding pain (visual analog scale: −6 [95% CI: −2.3 to −9.7], P = .014) and patient-reported outcome measures (American Shoulder and Elbow Surgeons: 23 [95% CI: 14.6-31.4], P = .003; Constant score: 38.8 [95% CI: 9.3-68.2], and P = .025; subjective shoulder value: 45 [95% CI: 0.5-89.5], P = .049). …”
    Get full text
    Article
  16. 8816

    Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignancies by Gita Thanarajasingam, Vishal Bhatnagar, Brie N. Noble, Ting-Yu Chen, Mallorie H. Fiero, Ron Hoffman, Molly Jeffery, Gina L. Mazza, John Mascarenhas, Ruben Mesa, Meena Murugappan, Joseph Ross, Surbhi Sidana, Rahma Warsame, Paul G. Kluetz, Amylou C. Dueck

    Published 2025-08-01
    “…Abstract Background The US Food and Drug Administration (FDA) released a draft guidance document detailing core patient-reported outcomes in cancer clinical trials, including physical function (PF). …”
    Get full text
    Article
  17. 8817

    Strategies for implementing long‐acting cabotegravir for PrEP in US clinics serving Black women: interim healthcare provider findings from the EBONI study by Katherine L. Nelson, Tammeka Evans Cooper, Yolanda Lawson, Dylan Baker, Satish Mocherla, Megan Dieterich, Theo Hodge, Alftan Dyson, Denise Sutherland‐Philips, Heidi Swygard, Lisa Petty, Peter Jeffery, Kenneth Sutton, Courtney Peasant Bonner, Sara M. Andrews, Samantha Chang, Piotr Budnik, Kimberly Smith, Annemiek deRuiter, Maggie Czarnogorski, Nanlesta Pilgrim

    Published 2025-07-01
    “…Useful implementation strategies unique to clinic types included using electronic medical records to document whether patients were offered CAB LA (PC), designating specific days for administering injections (WH) and creating time for discussion with patients (ID). …”
    Get full text
    Article
  18. 8818

    Screening log: Challenges in community patient recruitment for gynecologic oncology clinical trials by Rubina Ratnaparkhi, Gary C. Doolittle, Hope Krebill, Michelle Springer, Elizabeth Calhoun, Andrea Jewell, Dinesh Pal Mudaranthakam

    Published 2024-12-01
    “…Re-screening patients when new trials open may identify 12-15 additional patients per recurrent disease trial. …”
    Get full text
    Article
  19. 8819

    Suppression of the T-dependent antibody response following oral exposure to selected polycyclic aromatic compounds in B6C3F1/N mice by Victor J. Johnson, Cynthia V. Rider, Michael I. Luster, Cynthia J. Willson, Shawn Harris, Billie Stiffler, James Blake, Esra Mutlu, Veronica Godfrey, Brian Burback, Reshan Fernando, Suramya Waidyanatha, Gary R. Burleson, Dori R. Germolec

    Published 2025-03-01
    “…In addition, phenanthrene and pyrene, non-carcinogenic PACs, were tested at dose ranges between 12.5 and 800 mg/kg bodyweight/day and 3.1 and 200 mg/kg bodyweight/day, respectively. …”
    Get full text
    Article
  20. 8820

    Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety by N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. V. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin

    Published 2021-11-01
    “…Ventricular arrhythmias (exclusively Torsade de pointes tachycardia in excessive QT interval prolongation) were registered in 1.7% (12 of 727) patients: in 2% (9 of 451) of patients in primary center and in 1% (3 of 276) of patients of other hospitals; 95% CI: [-0.06; 0.08]. …”
    Get full text
    Article